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Imaging options for breast cancer detection have changed significantly over time. There are two goals that drive technological change in breast cancer imaging: a. 
improvement in diagnostic accuracy and b. reduction in 
radiation exposure to the breast. 
The gold standard for breast cancer detection has long 
been the standard two-plane mammogram; this was initially 
obtained using conventional film/screen technology and 
later with full field digital mammography (FFDM), which 
improved image quality and reduced radiation exposure.
Digital breast tomosynthesis (DBT) integrates 
tomography into digital mammographic technology. 
This imaging method obtains multiple slices through 
the thickness of the breast thereby reducing interference 
from tissue overlap, which is particularly advantageous in 
dense breasts. The current practice is to start with FFDM 
as the initial screening test and to proceed to DBT only if 
questionable findings are noted on FFDM. 
From a cancer detection standpoint, combining FFDM 
and DBT improves cancer detection rates (CDR), however 
this also leads to doubling in radiation dose delivered to 
the breast. Performing DBT alone is not recommended as it 
involves longer reading times and does not deliver the initial 
overview of the breasts provided by FFDM, which greatly 
aids cancer detection. 
Recent technological development in DBT has led to 
synthesised views (or S-views), which are single mammographic 
images created from the DBT data. An S-view image is similar 
to an FFDM mammogram. Using DBT/S-views reduces the 
radiation dose by 50% compared with FFDM/DBT combined. 
DBT with S-views may therefore be used as a primary cancer 
screening exam to replace FFDM/DBT. 
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Current scientific literature analysing over 30,000 screening 
exams has shown an improved CDR with DBT/S-views (9.3 
per 1000 screening exams) compared with FFDM (5.4 per 
1000 screening exams); the relative (detection) rate (RR) is 
1.72. Using DBT/S-view improves CDR irrespective of breast 
density, but the benefit is greater for dense breasts; RR for is 
2.86 for high density breasts and 1.52 for low density breasts.  
The positive predictive value (PPV), which is the proportion of 
correct positive diagnoses, using DBT/S-view (23.3%) is double 
that of FFDM (12.9%).1 
An important criterion for assessing a screening test is the 
recall rate; since mammograms are taken in the absence of a 
radiologist in most screening programs, patients need to be 
recalled for further investigation if the radiologist detects an 
abnormality. A very high recall rate is associated with significant 
Figure 1: Diagram showing movement of X-ray source to obtain 
slice images through the breast.
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were not practical due to limited detector technology and 
computing power. With the improvement of x-ray detectors 
and computing power, DBT systems have been increasingly 
introduced into clinical use over the past decade (Figure 2). 
DBT has been used to evaluate complex and equivocal findings 
as part of a diagnostic mammographic imaging work-up (Figures 
3 and 4), but its implementation for breast cancer screening was 
hindered due to increased radiation exposure it entails. 
By employing the latest development in DBT, namely the 
S-view, the radiation exposure is reduced to by half, which 
makes it acceptable for use in breast cancer screening. The 
diagnostic accuracy of the DBT/S-view is higher than that of 
the standard FFDM/DBT combination (Figure 5) according 
to the latest research.1 
Breast cancer is the most common cancer in women 
account for around 50% of all female cancers. The frequency 
of breast cancer and the availability effective treatment 
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justify regular screening for all women particularly those 
who have risk factors. The dense breast is one of the 
limitations of mammographic imaging and is also a risk 
factor for breast cancer. The S-view technology provides 
a more accurate and safe method of screening for breast 
cancer than was previously possible. This is particularly 
true when evaluating dense breasts. 
distress and expense, since many of the recalled patients will not 
have cancer. A low recall rate, however, may miss cancers. The 
recall rate for DBT/S-view is similar to FFDM. 
The review time required by the radiologist for DBT/S-view 
is however almost double that of FFDM. 
Similar results were obtained in earlier studies from 
different research groups;2 they described significant reduction 
in radiation dose using DBT/S-view technology compared with 
DBT/FFDM combination. 
Tomography uses a long-known principle that acquires a slice 
image through the body by moving the X-ray source and detector 
during the image acquisition (Figure 1). This movement retains 
in focus those structures that are at the focal point of rotation, 
while blurring all structure in front of and behind that plane 
of focus. The use of tomography started in the 1930s and was 
enhanced in the late 1960s and 1970s with the development of 
powerful computers that could handle large volumes of data fast. 
These technologies gave rise to Computed Tomography (CT), 
which is one of our most powerful diagnostic tools. 
Integration of tomography into breast imaging was suggested 
in the late 1990s, however prototype systems that were developed 
Figure 4: Zoomed image of a cancer (arrows) in a dense breast seen 
on FFDM (Left) and DBT (Right)
Figure 5: FFDM (Left) and S-view Mammogram (Right) of the same breast; 
microcalcifications (arrows) are shown more clearly on the S-view that on 
the FFDM (note zoomed inserts)
Figure 2: Clinical 
implementation of DBT
Figure 3: FFDM (Left) and DBT (Right) 
showing a cancer (arrows) in the lateral 
aspect of the left breast
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